Here is the synopsis of our sample research paper on Martha Stewart's Trial and Conviction. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 26 page paper discussing the facts, charges, court proceedings and appeal activities connected with Martha Stewart's trial and conviction. The paper is written for interest with a criminal law procedure focus. Bibliography lists 32 sources.
Page Count:
26 pages (~225 words per page)
File: CC6_KScrimLawProc7.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
are not included in the citation examples available at http://www.law.cornell.edu/citation. Cited here as any other web-based source because there are no case numbers associated with it at the Court
TV site. Introduction Scrutiny of the Martha Stewart case is amazingly unsatisfying in terms of being able to arrive at a set of
facts and conclusions that should be evident when justice has been served. It appears that both prosecutors and defense attorneys looked at everything but the obvious. It is
certain that the efforts of each side collectively provide clear support for the benefits of online trading and self-managed portfolios. Facts Martha Stewart
owned shares of ImClone stock at the end of 2001, when the stock was trading for around $74 a share. Immediately prior to the Food and Drug Administrations (FDA)
rejection of ImClones leading new drug for the purposes ImClone promoted it, Stewart instructed her broker, Peter Bacanovic, to sell her ImClone stock. Stewart and Bacanovic maintained that they
had agreed that Bacanovic would sell the stock if its price declined below $60; the government believed that Bacanovic informed Stewart that ImClones CEO Sam Waksal had sold much of
his stock and that Stewarts instructions resulted from that illicit information. The government claims that Stewart did not directly give a sell order
to Bacanovic, that Bacanovic instructed his assistant Douglas Faneuil to deliver the message to Stewart. Stewart does not recall having contact with Faneuil (Two Sides, n.d.).
A former stock broker well aware of the laws governing the trade of stock, Stewart denied that she had any knowledge of the FDAs rejection of
...